Down Syndrome Due to Unbalanced Homologous Acrocentric Rearrangements and its Recurrence in Subsequent Pregnancies: Prenatal Diagnosis by Amniocentesis

Accepted 22 October 2009.

Summary

Objective

To present our experience of amniocentesis for the prenatal diagnosis of Down syndrome due to unbalanced homologous acrocentric rearrangements and its recurrence in subsequent pregnancies.

Case Report

From January 1987 to September 2009, six cases with rea(21q21q) Down syndrome were diagnosed among 31,194 patients who underwent amniocentesis at Mackay Memorial Hospital, Taipei, Taiwan. Cytogenetic analysis of parental blood lymphocytes was performed in each case, and polymorphic DNA markers were used to investigate the nature of the aberrant chromosome. Three of the six cases were associated with recurrence in subsequent pregnancies. The rea(21q21q) Down syndrome was associated with advanced maternal age in three cases, a previous child with rea(21q21q) Down syndrome in three cases, an abnormal maternal serum screening result in one case, and an abnormal ultrasound finding in one case. All six cases arose de novo. Among the six cases with molecular analysis results, all had isochromosome 21, five of which were determined to be of maternal origin.

Conclusion

We found a frequency of 0.019% for rea(21q21q) Down syndrome in patients undergoing amniocentesis. Down syndrome caused by the homologous rearrangement rea(21q21q) can be associated with recurrence. Prenatal diagnosis of rea(21q21q) Down syndrome should include extensive cytogenetic and molecular analyses of the parents and probands.

Key Words: amniocentesis , Down syndrome , homologous acrocentric rearrangement , i(21q) , isochromosome , recurrence

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

• Summary

• References

• Copyright

References

1. 1 Bandyopadhyay R, McCaskill C, Knox-Du Bois C, Zhou Y, Berend SA, Bijlsma E, et al. Mosaicism in a patient with Down syndrome reveals post-fertilization formation of a Robertsonian translocation and isochromosome . Am J Med Genet A . 2003;116A:159–163 .

2. 2 Chen CP , Lin CJ , Wang W , the Taiwan Amniocentesis Collaborative Study Group . Impact of second-trimester maternal serum screening on prenatal diagnosis of Down syndrome and the use of amniocentesis in the Taiwanese population . Taiwan J Obstet Gynecol . 2005;44:31–35 . Abstract | Full-Text PDF (67 KB) | CrossRef

3. 3 Shaffer LG , McCaskill C , Haller V , Brown JA , Jackson-Cook CK . Further characterization of 19 cases of rea(21q21q) and delineation as isochromosomes or Robertsonian translocations in Down syndrome . Am J Med Genet . 1993;47:1218–1222 . MEDLINE | CrossRef

4. 4 Robinson WP , Bernasconi F , Basaran S , et al. A somatic origin of homologous Robertsonian translocations and isochromosomes . Am J Hum Genet . 1994;54:290–302 . MEDLINE

5. 5 Antonarakis SE , Adelsberger PA , Petersen MB , Binkert F , Schinzel AA . Analysis of DNA polymorphisms suggests that most de novo dup(21q) chromosomes in patients with Down syndrome are isochromosomes and not translocations . Am J Hum Genet . 1990;47:968–972 . MEDLINE

6. 6 Rothlisberger B , Schinzel A , Kotzot D . A new molecular approach to investigate origin and formation of structural chromosome aberrations . Chromosome Res . 2000;8:451–453 . MEDLINE | CrossRef

7. 7 Kovaleva NV , Shaffer LG . Under-ascertainment of mosaic carriers of balanced homologous acrocentric translocations and isochromosomes . Am J Med Genet . 2003;121A:180–187 . CrossRef

8. 8 Grasso M , Giovannucci Uzielli ML , Pierluigi M , Tavellini F , Perroni L , Dagna Bricarelli F . Isochromosome not translocation in trisomy 21q21q . Hum Genet . 1989;84:63–65 . MEDLINE | CrossRef

9. 9 Shaffer LG , Jackson-Cook CK , Meyer JM , Brown JA , Spence JE . A molecular genetic approach to the identification of isochromosomes of chromosome 21 . Hum Genet . 1991;86:375–382 . MEDLINE

10. 10 Robinson WP, Bernasconi F, Dutly F, Lefort G, Romain DR, Binkert F, et al. Molecular studies of translocations and trisomy involving chromosome 13 . Am J Med Genet . 1996;61:158–163 . MEDLINE | CrossRef

11. 11 Shaw SW , Chen CP , Cheng PJ , et al. Gene dosage change of TPTE and BAGE2 and breakpoint analysis in Robertsonian Down syndrome . J Hum Genet . 2008;53:136–143 . CrossRef

12. 12 Steinberg C , Zackai EH , Eunpu DL , Mennuti MT , Emanuel BS . Recurrence rate for de novo 21q21q translocation Down syndrome: a study of 112 families . Am J Med Genet . 1984;17:523–530 . MEDLINE | CrossRef

13. 13 Mark HFL , Mendoza T , Abuelo D , Beauregard LJ , May JB , LaMarche PH . Reproduction in a woman with low percentage t(21q21q) mosaicism . J Med Genet . 1977;14:221–223 . MEDLINE

14. 14 Jacobs PA , Mayer M , Rudak E . Structural chromosome abnormalities in Down syndrome: a study of two families . Cytogenet Cell Genet . 1978;20:185–193 . MEDLINE

15. 15 Wilroy RS , Summitt RL , Martens P . Reproduction in a woman with mosaicism . J Med Genet . 1978;15:406–407 . MEDLINE

16. 16 Croci G , Franchi F . Parental mosaicism in de novo translocation (21q21q) Down's syndrome . J Med Genet . 1991;28:502 . MEDLINE

17. 17 Yu CYC , Bonavita L , Anyane-Yeboa K , Brown SA , Krishna M , Warburton D . Gonadal mosaicism for a Robertsonian translocation: a search for the best reproductive options for a couple with five spontaneous abortions . Am J Hum Genet . 1998;63(Suppl):A156 .

18. 18 Hall BD . Recurrence risk in de novo 21q21q translocation Down syndrome . Am J Med Genet . 1985;22:417–418 . MEDLINE | CrossRef

a Department of Obstetrics and Gynecology, Taipei, Taiwan

b Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan

c Department of Biotechnology, Asia University, Taichung, Taiwan

d School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan

e Institute of Clinical and Community Health Nursing, Taipei, Taiwan

f Department of Obstetrics and Gynecology, School of Medicine, National Yang-Ming University, Taipei, Taiwan

g Department of Medical Genetics, Taipei, Taiwan

h Department of Medical Research, China Medical University Hospital, Taichung, Taipei, Taiwan

i Department of Bioengineering, Tatung University, Taipei, Taiwan

Correspondence to: Dr Chih-Ping Chen, Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan

PII: S1028-4559(09)60331-4

doi:10.1016/S1028-4559(09)60331-4

12 of 30